PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM
Through the Cloudy Lens – Outreach in the Top End
EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT- AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES
Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)
THE CLINICAL USE OF TOPICAL HYPERTONIC SALINE EYE DROPS IN A TERTIARY REFERRAL EYE CARE CENTRE IN SYDNEY, AUSTRALIA
VERTICAL PRISM FUSION RANGES IN A NORMAL POPULATION